Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q2 2026 · 10-Q
Revenue$34.17M$34.17Mno prior Q2 2025 on file Net Income-$6.16M-$6.16Mno prior Q2 2025 on file EPS Diluted-$0.19-$0.19no prior Q2 2025 on file The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,189,000— Free Cash Flowderived-$2,702,000— Margins · derivedGross margin35.3%
Operating margin7.5%
Net margin-18.0%
ended Jun 30, 2026 · filed Aug 5, 2026 · 36 d after period end